Table 1.
RRM2 expression and clinical characteristics of the 54 glioma patients.
| Clinicopathologic feature | n (%) | RRM2 | P-Value | ||
|---|---|---|---|---|---|
| Low | High | mean ± SEM | |||
| Age | P=0.266 | ||||
| ≤40 | 22 (40.74%) | 9 | 13 | 2.54±0.21 | |
| ≥40 | 32 (59.26%) | 14 | 18 | 2.60±0.18 | |
| Gender | P=0.2027 | ||||
| Female | 16 (29.62%) | 7 | 9 | 1.81±0.17 | |
| Male | 38 (70.37%) | 15 | 23 | 1.87±0.15 | |
| Surgery | P=0.3836 | ||||
| Biopsy | 8 (14.81%) | 3 | 5 | 2.31±0.24 | |
| Partial resection | 17 (31.48%) | 5 | 12 | 2.45±0.22 | |
| Gross total resection | 29 (53.71%) | 10 | 19 | 2.37±0.27 | |
| WHO Grade (%) | P<0.0001 | ||||
| ІІ | 16 (29.62%) | 6 | 10 | 1.71±0.23 | |
| ІІІ | 18 (33.33%) | 4 | 14 | 2.29±0.21 | |
| IV | 20 (37.05%) | 5 | 15 | 2.51±0.25 | |
| Low expression | 21 (39.00%) | 17 | 4 | 2.04±0.19 | P<0.0001 |
| High expression | 33 (61.00%) | 5 | 28 | 3.52±0.27 | |
| Tumor size | P=0.3388 | ||||
| <4cm | 23 (42.59%) | 11 | 12 | 2.45±0.22 | |
| ≥4cm | 31 (57.41%) | 13 | 18 | 2.39±0.23 | |
Statistical analyses were performed by the Pearson χ2 test. P < 0.05 was considered as statistically significant.